Comparative Study and Validation of New Methodologies for Measuring Addition
2 other identifiers
interventional
54
1 country
1
Brief Summary
The aim of this research is to collect comprehensive data on a presbyopic population that may require near vision correction, in order to identify the most useful tests to accurately determine the value of an addition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2025
CompletedFirst Submitted
Initial submission to the registry
April 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 8, 2025
CompletedJune 6, 2025
June 1, 2025
1 month
April 17, 2025
June 5, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Subject's age
The subject's age is requested via the Case Report Form
Day 1
Addition value given by the objective method
When you have presbyopia, the lens is no longer able to increase its power to accommodate near vision. It must then be helped by adding power for near vision, i.e., increasing the strength of the lens: this is called addition. The value of the addition is expressed in diopters (D) and is automatically measured by an auto-kerato-refractometer/aberrometer. It is an objective measure because it does not call upon the subject's responses when presented with acuity scales.
Day 1
Addition value given by the subjective method
When you have presbyopia, the lens is no longer able to increase its power to accommodate near vision. It must then be helped by adding power for near vision, i.e., increasing the strength of the lens: this is called addition. The value of the addition is expressed in diopters (D) and is automatically measured by an autorefractometer. It is a subjective measure because it calls upon the subject's responses when presented with acuity scales.
Day 1
Working distances for near vision
Several working distances are measured for near vision. The values of the distances are expressed in centimeters (cm). The various working distances for near vision are: * Harmon distance: the morphological distance from the elbow to the clenched fist * Revip distance (visuo-postural reflex): the subject is given a blank A4 sheet of paper and asked to hold it at their potential reading distance. * Desired distance: the distance at which a subject can read a Times 12 text on an A4 sheet of paper.
Day 1
Secondary Outcomes (2)
Quality of Vision questionnaire (Qov) score
Day 1
CISS questionnaire (Convergence Insufficiency Symptom Survey) score
Day 1
Study Arms (1)
Validation of new addition measurement methodologies
EXPERIMENTALInterventions
VA will be measured for near and distance vision with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart
Objective refraction will be measured using an auto-kerato-refractometer/aberrometer
Standard subjective refraction for distance vision will be performed with Vision-R™
Near vision examination and determination of additions will be performed with Vision-R™. The following objective and subjective measurement methods will determine the values of the various additions: 1. Determination of addition using the retinoscopy method (Add\_OBJ) 2. Randomization and administration of addition determination tests: FCC; R/G; PRA-NRA
The following measurements will be taken in trial glasses equipped with the final addition: 1. Stereoscopic acuity measurement 2. Measurement of the Near Point of Accommodation (PPA) 3. Measurement of the Near Point of Convergence (PPC) 4. Measurement of fusion reserves 5. Measurement of prismatic rock 6. Subjective questionnaire on the different methods used
The following measurements will be performed using trial glasses equipped with the final addition: 1. Submission of the CISS questionnaire and distance adaptation 2. Initial measurements of accommodative positioning and phorias 3. Completion of three smartphone tasks: reading, memorization, and video viewing 4. Final measurements of accommodative positioning and phorias 5. Submission of the QoL questionnaire regarding visual discomfort during the trial.
Eligibility Criteria
You may qualify if:
- Volunteer, fluent in French, willing to follow the protocol, able to read and understand the information form and give free and informed consent
- Aged 40 to 60 years
- Individual with monocular visual acuity ≥ +0.1 LogMAR with current corrections and pinhole if necessary
- Individual with a visual acuity difference ≤ 0.2 LogMAR with current corrections
- Individual with stable binocular vision in distance and near vision
You may not qualify if:
- Age \< 40 years (i.e., no minors in accordance with Article L1121-7)
- Age \> 60 years
- All categories of people specifically protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code):
- Pregnant, childbearing, or breastfeeding women (Article L1121-5)
- Persons deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent pursuant to Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8 and persons admitted to a health or social care facility for purposes other than research
- Adults incapable or unable to express consent (Article L1121-8)
- Participants currently excluded from another study
- Participants unable to be contacted in case of emergency
- Person with strabismus
- Person with amblyopia
- Aphakic or pseudophakic person
- Person with vertical phoria \> 1 PD
- Declared neurological deficit, including a history of epileptic disorders or sensory-motor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders)
- Declared severe ocular pathology, involving visual field loss, such as glaucoma, or involving loss of acuity and significant discomfort in dimly or excessively lit environments, such as retinitis pigmentosa, or declared and treated dry eye.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Essilor International - Ci&T 2
Créteil, 94000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François Daniel
ESSILOR INTERNATIONAL - Division Instruments
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2025
First Posted
May 8, 2025
Study Start
March 31, 2025
Primary Completion
May 5, 2025
Study Completion
May 5, 2025
Last Updated
June 6, 2025
Record last verified: 2025-06